Description: Learn about IDACIO® (adalimumab-aacf), an FDA-approved biosimilar for HUMIRA® (adalimumab) made by Fresenius Kabi. See safety, dosing, & full prescribing info.
Idacio ® (adalimumab-aacf) injection, for subcutaneous use, is an FDA-approved biosimilar of Humira ® (adalimumab)
*Not commercially available before July 2023.
Patients treated with IDACIO ® (adalimumab-aacf) are at increased risk for developing serious infections that may lead to hospitalization or death. Most patients who developed these infections were taking concomitant immunosuppressants such as methotrexate or corticosteroids.